News & Articles

AI Drug Safety startup Sable Bio raises $3.75M seed, backed by growing pharma adoption

11 Feb 2026

Sable Bio raises $3.75M seed funding led by MMC Ventures to accelerate our drug safety platform.

Some of the Sable team at work in our messy new office

Software Engineering at Sable

19 Jan 2026

How we approach software engineering at Sable, and how we optimise our time for impactful and interesting work.

Sable is SOC2 Type II Compliant

26 Sept 2025

Sable is proud to be SOC 2 Type II compliant, an indicator of the care we take with customer data.

Sable: Our Journey So Far

27 Jan 2025

Sable has spent 2024 building a platform to transform how scientists assess drug safety, culminating in our first major pharmaceutical partnership in 2025.

A pod of dolphins swimming in the same direction

Sable is Expanding

20 Jan 2025

After a year of work on our platform, the time has come for the team to grow. If you're interested in our mission please get in touch today!

CAS Innovation Incubator

4 Nov 2024

We're excited to be part of the CAS Innovation Incubator program, a division of the American Chemical Society

Meet Sable this Autumn

1 Oct 2024

The Sable team will be out at various conferences in October. Come and say hi.

Sable First Birthday

3 Sept 2024

In August 2024 we celebrated Sable's first birthday - after a year in which a lot has changed

Target Safety Assessments

2 Sept 2024

An overview of target safety assessments and our approach to making them better

Welcome Juha

1 Jul 2024

Meet Juha, our new Director of AI, the multi-talented Juha.

Meet Sable Bio at Upcoming Events

You’ll find Sable Bio at key scientific and industry events throughout the year. Join us to discuss target safety, see what we’re building, and meet the team.

Meet Sable Bio at Upcoming Events

You’ll find Sable Bio at key scientific and industry events throughout the year. Join us to discuss target safety, see what we’re building, and meet the team.